Actieve functies van Andreas Klostermann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
selectION, Inc.
 selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Directeur/Bestuurslid | - | - |
| Hoofd Techniek/Wetenschap/O&O | - | - | |
| Oprichter | - | - | |
| The Education Foundation of the Forest Lake Area | Directeur/Bestuurslid | - | - |
Loopbaan van Andreas Klostermann
Eerdere bekende functies van Andreas Klostermann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
conoGenetix biosciences GmbH
 conoGenetix biosciences GmbH Pharmaceuticals: MajorHealth Technology conoGenetix biosciences GmbH develops peptide-based drugs and new ion channel selective drugs. It runs programs targeting severe autoimmune disorders like multiple sclerosis, rheumatoid arthritis, and vasculitis. The firm development pipeline encompasses peptide design, electrophysiology testing, biophysical parameters and synthesis, proliferation assays, and animal testing and toxicology. The company was founded by Andreas Klostermann, Mira Klostermann and Jörg Stockhaus in March 2002 and is headquartered in Planegg, Germany. | Algemeen Directeur | 01-01-2002 | 01-10-2017 |
| Oprichter | 01-01-2002 | 01-10-2017 |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Duitsland | 2 |
Operationeel
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
conoGenetix biosciences GmbH
conoGenetix biosciences GmbH Pharmaceuticals: MajorHealth Technology conoGenetix biosciences GmbH develops peptide-based drugs and new ion channel selective drugs. It runs programs targeting severe autoimmune disorders like multiple sclerosis, rheumatoid arthritis, and vasculitis. The firm development pipeline encompasses peptide design, electrophysiology testing, biophysical parameters and synthesis, proliferation assays, and animal testing and toxicology. The company was founded by Andreas Klostermann, Mira Klostermann and Jörg Stockhaus in March 2002 and is headquartered in Planegg, Germany. | Health Technology |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | Health Technology |
| The Education Foundation of the Forest Lake Area |
- Beurs
- Insiders
- Andreas Klostermann
- Ervaring
